Genetic diversity in pediatric patients with inborn errors of immunity in Russia

Cover Page

Cite item

Full Text

Abstract

To date, about 500 genetic defects are known to cause clinical manifestations of immunodeficiency. Genetic diagnosis is necessary to guide the management of patients with inborn errors of immunity (IEI) and plays an important role in genetic counselling of families. To find the genetic cause of IEI, 2395 probands were tested, in 1507 (65.7%) of them we identified 164 forms of IEI with defects in 143 single genes and abnormalities in 8 chromosomes. The majority of IEIs (89.1%) were monogenic, with 98.6% of them being of germline origin. Only 10.6% of IEIs were due to large chromosomal breaks. The most common monogenic forms of IEI with a confirmed genetic defect are Wiskott–Aldrich syndrome, X-linked chronic granulomatous disease, X-linked agammaglobulinemia, Nijmegen syndrome, hereditary angioedema types 1 and 2, ataxia-telangiectasia, Schwachman–Diamond syndrome, severe congenital neutropenia, X-linked severe combined immunodeficiency. Among IEIs associated with chromosomal abnormalities, del22.q11.2 syndrome (DiGeorge syndrome) predominates. These 10 forms of IEI were detected in 51% (775/1507) of all the probands with a confirmed genetic diagnosis. In our study, 6.4% (96/1507) of the probands had unique IEIs: a total of 80 different IEI entities associated with defects in 73 genes and 6 chromosomes (each entity affecting 1 or 2 patients). The majority of them were autosomal recessive IEIs (65%), 30% were autosomal dominant, and only 5% of the cases were X-linked. In addition, polygenic IEIs were identified in 0.3% of the probands and somatic mutations in wellknown genes (NRAS, KRAS, FAS, NLRP3) led to IEI in 0.9% of the probands. The frequency of familial cases among the probands with a confirmed genetic diagnosis was 9.6% (145/1507). Understanding the mechanisms of occurrence and inheritance of IEI in the heterogeneous Russian population will play an important role in the development of diagnostic and therapeutic strategies for patients and their families. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. Informed consent for genetic testing and for the publication of its results was obtained from the patients and/or from at least one parent of a child under the age of consent.

About the authors

N. B. Kuzmenko

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: plunge@list.ru
ORCID iD: 0000-0002-1669-8621

Natalia B. Kuzmenko, Cand. Med. Sci., Head of the Department of Epidemiology and Monitoring of Immunodeficiencies, an allergist-immunologist at the Outpatient Department,

1 Samory Mashela St., 117997, Moscow

Russian Federation

M. A. Alexenko

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

A. A. Mukhina

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-3305-1694

Moscow

Russian Federation

Yu. A. Rodina

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0001-9857-4456

Moscow

Russian Federation

M. S. Fadeeva

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

D. E. Pershin

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-6148-7209

Moscow

Russian Federation

A. M. Kieva

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

T. V. Varlamova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

D. V. Yukhacheva

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0001-9078-8206

Moscow

Russian Federation

V. I. Burlakov

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

N. Yu. Kan

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

E. V. Deripapa

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-9083-4783

Moscow

Russian Federation

A. L. Kozlova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-2869-6535

Moscow

Russian Federation

Z. A. Nesterenko

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

A. Ya. Avedova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

A. A. Moiseeva

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

E. A. Deordieva

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

O. A. Shvets

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

E. A. Viktorova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

A. O. Bludova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

A. L. Ogneva

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

D. V. Bogdanova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

I. V. Mersiyanova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

E. V. Raykina

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-7634-2053

Moscow

Russian Federation

M. A. Maschan

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

G. A. Novichkova

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

N. S. Grachev

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Moscow

Russian Federation

A. Yu. Shcherbina

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

ORCID iD: 0000-0002-3113-4939

Moscow

Russian Federation

References

  1. Tangye S.G., Al-Herz W., Bousfiha A., Cunningham-Rundles C., Franco J.L., Holland S.M., et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 2022; 42 (7): 1473–507. doi: 10.1007/s10875-022-01289-3
  2. Bousfiha A., Moundir A., Tangye S.G., Picard C., Jeddane L., Al-Herz W., et al. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol 2022; 42 (7): 1508–20. doi: 10.1007/s10875-022-01352-z
  3. Notarangelo L.D., Sorensen R. Is it necessary to identify molecular defects in primary immunodeficiency disease? J Allergy Clin Immunol 2008; 122: 1069–73. doi: 10.1016/j.jaci.2008.08.038
  4. Abolhassani H., Azizi G., Sharifi L., Yazdani R., Mohsenzadegan M., Delavari S., et al. Global systematic review of primary immunodeficiency registries. Expert Rev Clin Immunol 2020; 16 (7): 717–32. doi: 10.1080/1744666X.2020.1801422
  5. El-Helou S.M., Biegner A.K., Bode S., Ehl S.R., Heeg M., Maccari M.E., et al. The German National registry of primary immunodeficiencies (2012–2017). Front Immunol 2019; 10: 1272. doi: 10.3389/fimmu.2019.01272
  6. Marschall K., Hoernes M., Bitzenhofer-Grüber M., Jandus P., Duppenthaler A., Wuillemin W.A., et al. The Swiss National Registry for Primary Immunodeficiencies: report on the first 6 years’ activity from 2008 to (2014). Clin Exp Immunol 2015; 182: 45–50. doi: 10.1111/cei.12661
  7. Naidoo R., Ungerer L., Cooper M., et al. Primary immunodeficiencies: a 27-year review at a tertiary paediatric hospital in Cape Town, South Africa. J Clin Immunol 2011; 31 (1): 99–105.
  8. Deripapa E., Balashov D., Rodina Y., Laberko A., Myakova N., Davydova N.V., et al. Prospective Study of a Cohort of Russian Nijmegen Breakage Syndrome Patients Demonstrating Predictive Value of Low Kappa– Deleting Recombination Excision Circle (KREC) Numbers and Beneficial Effect of Hematopoietic Stem Cell Transplantation (HSCT). Front Immunol 2017; 8: 807. doi: 10.3389/fimmu.2017.00807
  9. Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol 2017; 36 (8): 1707–13. doi: 10.1007/s10067-017-3715-5
  10. European Society for Immunodeficiencies. Registry Working Party Diagnosis Criteria. (2018). [Electronic resource] URL: https://esid.org/Working-Parties/RegistryWorking-Party/Diagnosis-criteria (accessed December 3, 2019).
  11. Mukhina A.A., Kuzmenko N.B., Rodina Yu.A., Kondratenko I.V., Bologov A.A., Latysheva T.V., et al. Primary Immunodeficiencies in Russia: Data From the National Registry. Front Immunol 2020; 11: 1491. doi: 10.3389/fimmu.2020.01491
  12. Kuzmenko N., Alexenko M., Mukhina A., Rodina Y., Fadeeva M., Pershin D., et al. Genetic Characteristics of a Large Pediatric Cohort of Patients with Inborn Errors of Immunity: Single-Center Experience. J Clin Immunol 2024; 44: 165. doi: 10.1007/s10875-024-01767-w
  13. Jindal A.K., Pilania R.K., Rawat A., Singh S. Primary Immunodeficiency Disorders in India-A Situational Review. Front Immunol 2017; 8: 714. doi: 10.3389/fimmu.2017.00714
  14. Zakharova V., Raykina E., Mersiyanova I., Deordieva E., Pershin D., Vedmedskia V., et al. Cancer-causing MAP2K1 mutation in a mosaic patient with cardio-facio-cutaneous syndrome and immunodeficiency. Hum Mutat 2022; 43 (12): 1852–5. doi: 10.1002/humu.24463
  15. Terentieva A.I., Viktorova E.A., Zakharova V.V., Konovalov D.V., Burlakov V.I., Rodina J.A., et al. Clinical case of proteasome-associated autoinflammatory syndrome-2 (PRAAS2). Pediatric Hematology/Oncology and Immunopathology 2019; 18 (2): 108–13. (In Russ.) doi: 10.24287/1726-1708-2019-18-2-108-113
  16. Le Coz C., Nguyen D.N., Su C., Nolan B.E., Albrecht A.V., Xhani S., et al. Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients. J Exp Med 2021; 218 (7): e20201750. doi: 10.1084/jem.20201750
  17. Maffucci P., Filion C.A., Boisson B., Itan Y., Shang L., Casanova J.-L., Cunningham-Rundles C. Genetic Diagnosis Using Whole Exome Sequencing in Common Variable Immunodeficiency. Front Immunol 2016; 7: 220. doi: 10.3389/fimmu.2016.00220
  18. Seleman M., Hoyos-Bachiloglu R., Geha R.S., Chou J. Uses of Next-Generation Sequencing Technologies for the Diagnosis of Primary Immunodeficiencies. Front Immunol 2017; 8: 847. doi: 10.3389/fimmu.2017.00847
  19. Seidel M.G., Kindle G., Gathmann B., Quinti I., Buckland M., van Montfrans J., et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. J Allergy Clin Immunol Pract 2019; 7 (6): 1763– 70. doi: 10.1016/j.jaip.2019.02.004
  20. Abraham R.S., Butte M.J. The New “Wholly Trinity” in the Diagnosis and Management of Inborn Errors of Immunity. J Allergy Clin Immunol Pract 2021; 9 (2): 613–25. doi: 10.1016/j.jaip.2020.11.044
  21. Al-Saud B., Al-Mousa H., Al Gazlan S., Al-Ghonaium A., Arnaout R., Al-Seraihy A., et al. Primary Immunodeficiency Diseases in Saudi Arabia: a Tertiary Care Hospital Experience over a Period of Three Years (2010–2013). J Clin Immunol 2015; 35 (7): 651–60.
  22. Boocock G.R., Morrison J.A., Popovic M., Richards N., Ellis L., Durie P.R., Rommens J.M. Mutations in SBDS are associated with Shwachman–Diamond syndrome. Nat Genet 2003; 33 (1): 97–101. doi: 10.1038/ng1062
  23. Garelli S., Dalla Costa M., Sabbadin C., Barollo S., Rubin B., Scarpa R, et al. Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients. J Endocrinol Invest 2021; 44: 2493–510. doi: 10.1007/s40618-021-01585-6
  24. Heino M., Peterson P., Kudoh J., Shimizu N., Antonarakis S.E., Scott H.S., et al. APECED mutations in the autoimmune regulator (AIRE) gene. Hum Mutat 2001; 18 (3): 205–11. doi: 10.1002/humu.1176
  25. Orlova E.M., Sozaeva L.S., Karmanov M.E., Breivik L.E., Husebye E.S., Kareva M.A. The new immunological methods for diagnostics of type 1 autoimmune polyendocrine syndrome (the first experience in Russia). Problems of Endocrinology 2015; 61 (5): 9–13. (In Russ.) doi: 10.14341/probl20156159-13

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Kuzmenko N.B., Alexenko M.A., Mukhina A.A., Rodina Y.A., Fadeeva M.S., Pershin D.E., Kieva A.M., Varlamova T.V., Yukhacheva D.V., Burlakov V.I., Kan N.Y., Deripapa E.V., Kozlova A.L., Nesterenko Z.A., Avedova A.Y., Moiseeva A.A., Deordieva E.A., Shvets O.A., Viktorova E.A., Bludova A.O., Ogneva A.L., Bogdanova D.V., Mersiyanova I.V., Raykina E.V., Maschan M.A., Novichkova G.A., Grachev N.S., Shcherbina A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.